HopeStage
Back to all studies
UnknownNCT00452231

RCT of CBT Combined With D-Cycloserine for Treating PTSD

Medication studyAges 18–65Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
MontrealSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2007
Recruitment status
Unknown
Enrollment listed in the registry
20
Sponsor
Université de Montréal
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT00452231
Official title
Show the full official title

Comparative Study of the Efficacy of a Cognitive-Behavioral Therapy for Post-Traumatic Stress Disorder With or Without D-Cycloserine

Recruitment & locations

Status unknown

Montreal

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Université de Montréal, a university.

Does this study involve medication?

Yes. The study involves medication, including D-cycloserine.

Who can participate?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies